September 24, 2018 | Local, Aerospace

U.S. approves Canada's purchase of used Australia fighter jets - deal to be completed by end of year

DAVID PUGLIESE, OTTAWA CITIZEN

The sign-off from the Americans for the 25-jet purchase was needed because the aircraft were built in the U.S. with U.S. technology.

The U.S. government has approved Canada's purchase of used F-18 fighter jets from Australia, paving the way for the deal to be completed by the end of the year.

The sign-off from the Americans was needed because the aircraft were built in the U.S. with U.S. technology.

Dan Le Bouthillier of the Department of National Defence said Friday negotiations with Australia over the sale of the 25 used fighter jets is on-going.

“Should all negotiations and approvals move forward as planned, aircraft would start arriving in Canada in 2019, and the project remains on track to achieve this milestone,” he said. “The delivery plan, including mode of delivery, will be finalized once negotiations are complete and the aircraft being purchased are selected.”

In June, Postmedia reported that Canada had boosted the number of used Australian fighter jets it is purchasing to 25 from 18 but that the deal still hinged on approval from the U.S. government.

Although U.S.-Canada relations have hit a slump, with President Donald Trump vowing to punish Canadians because of ongoing trade disputes, DND officials hope the situation won't affect approvals for the fighter jet sale to proceed.

The Liberal government originally announced it would buy 18 used Australian F-18 jets to augment the Royal Canadian Air Force's CF-18s until new aircraft can be purchased in the coming years. But it has added seven more used Australian F-18 aircraft to the deal.

Those extra aircraft will be stripped down for parts or used for testing.

The exact cost of purchasing the 25 aircraft, along with weapons and other equipment, is not yet known, Procurement Minister Carla Qualtrough pointed out earlier this year. The Liberal government has set aside up to $500 million for the project.

Earlier this year, Pat Finn, the Department of National Defence's assistant deputy minister of materiel, said the government has received what's called a letter of cost proposal on the impending sale. “The Australians have now gone to the U.S. State Department for the transfer under ITAR,” Finn explained to MPs on the Commons defence committee at the time.

Finn indicated the DND wants to have the deal in place by the end of this year. “The idea of firming this up in the fall of 2018 was for the start of delivery of the two first aircraft to be next summer, and then quickly beyond it,” he added.

The federal government has confirmed the Australian aircraft will be operating alongside the RCAF's other CF-18s at Bagotville, Que., and Cold Lake, Alta. “The aircraft will be employed at 3 Wing Bagotville and 4 Wing Cold Lake,” a government official noted. “DND is currently reviewing infrastructure requirements to accommodate the additional aircraft. Any modifications are expected to be minimal as the supplemental jets are of similar age and design to the CF-18.”

The Liberal government had planned to buy 18 new Super Hornet fighter jets from U.S. aerospace giant Boeing.

But last year Boeing complained to the U.S. Commerce Department that Canadian subsidies for Quebec-based Bombardier allowed it to sell its C-series civilian passenger aircraft in the U.S. at cut-rate prices. As a result, the Trump administration brought in a tariff of almost 300 per cent against the Bombardier aircraft sold in the U.S.

In retaliation, Canada cancelled the deal to buy the Super Hornets. That project would have cost more than US$5 billion.

https://theprovince.com/news/politics/u-s-approves-canadas-purchase-of-used-australia-fighter-jets-deal-to-be-completed-by-end-of-year/wcm/f39380f7-98e9-45a2-8a7b-525c3eda6901

On the same subject

August 6, 2019 | Local, Naval

Planbox Partners With the Royal Canadian Navy
QUEBEC CITY and MONTREAL, Aug. 6, 2019 /CNW/ -- Planbox, a leading provider of cloud-based AI-Powered Agile Innovation Management solutions, today announced its partnership with the Royal Canadian Navy (RCN). A versatile, multipurpose and combat-capable naval force, the RCN will trial Planbox's AI-powered cloud-based agile innovation management solution as part of its innovation program. "Through the PSPC Built in Canada Innovation Program, the RCN has partnered with Montreal-based Planbox to trial their innovation management solution. As a matching agency for this technology, access to this tool will support the RCN's focus on becoming a more agile, digitally-enabled organization," said Rear-Admiral Casper Donovan of the Director General Future Ship Capability. Planbox will provide an innovation management platform through which the RCN's innovation program can gather insights from defined external data sources, and centralize key information in relation to specific problems it is solving, allowing it to accordingly leverage its technology experts to develop the appropriate solutions. "Working with the Royal Canadian Navy has been an incredible experience as we have enabled them to strategically map out their innovation portfolio and define their targets," said Arthur Liberian, Senior Innovation Advisor at Planbox. "We have helped them significantly in their pursuit for tangible innovation results by giving them the ability to view strategic information about their innovation portfolio on demand, allowing them to identify their most impactful opportunities." The RCN intends to use Planbox's powerful crowdsourcing capabilities to develop, evaluate, vet, rank and score ideas to help with its mission to improve conditions for investment, and enhance Canada's overall innovation performance. "It is an absolute honor for both myself and the Planbox team to have this one-of-a-kind opportunity to help our brave men and women in the Navy accelerate their operational agility," said Ludwig Melik, CEO at Planbox. For more information about Planbox's Agile Innovation Management Solutions, visit our website. About Planbox Planbox is the pioneering provider of cloud-based AI-Powered Agile Innovation Management solutions – from creative ideas to winning projects. Our mission is to help organizations thrive by transforming the culture of agile work, continuous innovation, and creativity across the entire organization. Our family of products includes Collaborative Innovation Management, Team Decision Making, and Work Management applications. Planbox is designed to provide agile innovation tools for everyone, built for companies and teams of all sizes. Planbox is the comprehensive innovation solution trusted by some of the world's most recognized brands, including Blue Cross, Cargill, Caterpillar, Dow Chemical, Exxon Mobil, Honeywell, John Deere, Novartis, Ontario Power Generation, Sun Life Financial, Whirlpool and Verizon, with millions of internal and external users. About the Royal Canadian Navy The Royal Canadian Navy (RCN) is Canada's naval force consisting of approximately 8,300 Regular Force and 3,600 Reserve sailors, supported by around 3,800 civilian employees. The mission of the Royal Canadian Navy is to generate combat-capable, multipurpose maritime forces that support Canada's efforts to participate in security operations anywhere in the world, as part of an integrated Canadian Armed Forces. Contact Information Lucas Potasso-Justino Marketing Specialist +1 (855) 752-6269 ext 608 lucas.potasso@planbox.com https://www.newswire.ca/news-releases/planbox-partners-with-the-royal-canadian-navy-880731141.html
June 26, 2023 | Local, Aerospace

Retombées économiques des F-35 | Beaucoup de latitude pour calculer les promesses
Il y aura beaucoup de latitude pour calculer les retombées économiques découlant de l’achat des 88 avions de chasse F-35 par Ottawa pour 19 milliards. Selon une présentation gouvernementale consultée par La Presse, les ententes entre le Canada et les constructeurs des avions de combat sont « non contractuelles », donc pas régies par un contrat.
March 27, 2020 | Local, Aerospace, Naval, Land, C4ISR, Security

NRC COVID-19 response
The Government of Canada is taking strong and quick action to protect our economy, and the health and safety of all Canadians during this global outbreak of the novel coronavirus (COVID-19). We are working with our partners as part of the collective effort to help find solutions to the COVID-19 outbreak: 1. The COVID-19 Challenges Procurement Program: NRC Industrial Research Assistance Program and Innovative Solutions Canada Purpose: This program will post challenges seeking near-to-market solutions from small and medium-sized businesses (fewer than 500 staff) that need financial support from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) to refine and sell their product or solution to meet a COVID-19 related need. NRC IRAP works with roughly 8,000 small and medium-sized businesses every year through its cross-Canada network of 255 industrial technology advisors and provides over $300 million in support to more than 3,000 technology development projects annually Through this initiative, the Public Health Agency of Canada (PHAC) and Health Canada (HC) will establish a number of challenges corresponding to needs of health providers to deal with COVID-19 NRC IRAP will partner with Innovative Solutions Canada to launch calls for proposals over the next few weeks to address challenges, fund development of solutions, and buy successful products and services needed to address COVID-19 Together, NRC IRAP and Innovative Solutions Canada will: post the PHAC and HC challenges (Innovative Solutions Canada) award Phase 1 funding to successful small and medium-sized businesses to develop a proof of concept for their solution (NRC IRAP) award Phase 2 funding to the firms with the best concepts so they can develop a working prototype (NRC IRAP) The NRC, PHAC, HC or another federal department or agency will then be able purchase the product for use against COVID-19. Innovative Solutions Canada already has challenges in development, which they will begin posting to their website in the coming days. These will continue as PHAC, HC, and health care providers request new topics. Companies with promising technology relevant to the COVID-19 challenges can register their technology or product by clicking on the Register button below. Register 2. The Pandemic Response Challenge Program: National Research Council of Canada Purpose: This program will build teams to address challenges requiring further research and development for solutions to meet COVID-19 related needs. The NRC will build these teams drawing on internal-to-government capacity and academic researchers who register using the button below to indicate their interest, and related areas of expertise and capabilities. The NRC will receive $15M to form dedicated teams to address challenges in the areas of greatest research and development (R&D) need in the fight against COVID-19. The NRC Pandemic Response Challenge Program will accelerate the development of diagnostics and medical countermeasures for a rapid front-line response to protect and treat Canadians. This national vehicle will convene the best Canadian and international researchers from academia and small and medium-sized businesses to collectively accelerate R&D to address specific COVID-19 gaps and challenges as identified by Canadian health experts. The Pandemic Response Challenge Program is currently structured around 3 main research areas: Rapid detection and diagnosis Therapeutics and vaccine development and Digital health. Researchers at Canadian and international universities, government departments, colleges, and highly innovative firms with relevant expertise can now register their interest to work with us on these challenges by clicking the Register button below. Funding is available to help cover the costs of research for academic institutions, small and medium-sized businesses, and other eligible recipients participating in the challenge teams. Over the coming weeks, we will post the specific R&D challenges, send information to registered researchers, and invite them to indicate the expertise and capabilities they can bring to a team. Register 3. Biomanufacturing capacity at Royalmount: NRC Human Health Therapeutics Research Centre Purpose: This initiative will result in a Good Manufacturing Practices platform to develop and scale up COVID-19 Canadian vaccine and therapy candidates. The NRC Biomanufacturing facility, located in the NRC's Royalmount Avenue building in Montréal, is used to develop and scale up processes to produce biological medicines and is managed by the Human Health Therapeutics Research Centre. As part of its development capacity, the facility is equipped with pilot-scale bioreactors (200 L and 500 L), which will be operationally available to produce up to 100,000 doses of vaccine per month within 6 months once a vaccine suitable for front-line responders is available. A $15 million investment will fund the certification of the facility for Good Manufacturing Practices compliance, and will enable production of material that will be used in humans, particularly for vaccines or therapeutics. This certification can also greatly increase the capacity for candidate vaccines or therapeutics to be quickly rolled out and clinically tested, particularly those originating from Canada. The work to refine and certify quality systems at the facility will include: bringing the existing facility to regulatory standards, installing equipment to expand capacity, and managing information. Once certified, this facility will be able to accelerate the scale-up production and testing of various types of vaccine candidates in the context of the current COVID-19 outbreak, including protein-based, viral vector-based, and antibody-based products. https://nrc.canada.ca/en/research-development/research-collaboration/nrc-covid-19-response

All news